Indivior claims federal law prevented it from updating the Suboxone tooth decay warnings before June 2022, indicating that thousands of lawsuits should be dismissed.
Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Suboxone manufacturers received complaints about dental damage from the film strips for years before adding label warnings about the risk of tooth decay and erosion, lawsuit claims.
Census of all Suboxone lawsuits will help the parties determine which tooth decay claims could be used as representative samples in early bellwether trials.
Manufacturers should have known about and failed to disclose risks of painful kratom withdrawal symptoms.
Suboxone tooth decay data will be produced as the parties work to exchange information needed to select a representative group of lawsuits for early bellwether trials.
Lawyers will meet with the MDL judge presiding over all Suboxone tooth decay lawsuits on October 4 and 5, to finalize information needed to select the first cases for bellwether discovery and trials.
A report will be submitted next week about the status of investigations into thousands of Suboxone dental injury lawsuits filed on a bundled complaint.
Lawyers are expected to discuss how to select a representative group of claims involving Suboxone dental injuries during a meeting with the Court on October 5.
In response to a motion to dismiss filed by Indivior, plaintiffs indicate that the drug maker knew about the risk of tooth decay problems from Suboxone long before the FDA required an update to the label warning.
